Treatment of actinic keratoses with alpha.sub.2 interferon

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 854, A61K 3766

Patent

active

050027646

ABSTRACT:
A method of treating actinic keratoses with alpha.sub.2 interferon is disclosed.

REFERENCES:
patent: 4605555 (1986-08-01), Sato et al.
Yancey et al., Am. Acad. Dermatol., 3, No. 6 (1980), 585-595.
Rubenstein, Biochem. Biophys. Acta, 695 (1982), 5-16.
Nagata et al., Nature, 284, (1980), 316-320.
Edwards et al., Arch. Dermatol., 122 (Jul., 1986) pp. 779-782.
Langer et al. J. of Invest. Dermatology 83, (1984), pp. 1285-1365.
Yusk, Current Therapy, ed. Comm, pp. 643-645, 1979.
Ikic et al., The Lancet, pp. 1025-1027, May 9, 1981.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of actinic keratoses with alpha.sub.2 interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of actinic keratoses with alpha.sub.2 interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of actinic keratoses with alpha.sub.2 interferon will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-616126

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.